To read the full story, subscribe or sign in.

Sirnaomics files first China IND for siRNA trial; U.S. filing next

Jan. 20, 2015

By Shannon Ellis

No Comments

SHANGHAI – Sirnaomics Inc. is a biopharma straddling the pacific.

BioWorld

Today's news in brief

BioWorld

BioWorld briefs for Dec. 12, 2024.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for December 12, 2024.

Second insulin receptor offers new therapeutic avenues

BioWorld Science

Investigators at the Helmholtz Institute have shown that inceptor, an inhibitor of the insulin signaling pathway, acted by binding insulin and targeting it for...

Keros stock wilts as it halts two dosing arms in hypertension study

BioWorld

After Keros Therapeutics Inc.’s voluntary halt of dosing in two arms of its phase II study in pulmonary arterial hypertension, the company’s stock crumpled after...

KITE-753, a rapid manufactured CAR T therapy with superior antitumor efficacy and enhanced expansion in vivo

BioWorld Science

In a presentation at the recent American Society of Hematology meeting in San Diego, Kite Pharma Inc. reported preclinical data for KITE-753, an autologous rapid...

Upgrade your daily dose of biopharma and medtech news

Sirnaomics files first China IND for siRNA trial; U.S. filing next